| ²é¿´: 552 | »Ø¸´: 1 | ||
taizicunÒø³æ (ÖøÃûдÊÖ)
|
[ÇóÖú]
Ò»¸öƤ·ô²¡Ò©ÎïFDA˵Ã÷Êé·ÒëºÍÀí½âÎÊÌâ
|
|
Ò»¸öƤ·ôÍâÓÃÒ©ÎïFDA˵Ã÷ÊéÆäÖеÄÕÂ½Ú ¡°Carcinogenesis, Mutagenesis, Impairment of Fertility: Long-term animal studies have not been performed to evaluate the carcinogenic potential of ELOCON (mometasone furoate cream) Cream, 0.1%. Long-term carcinogenicity studies of mometasone furoate were conducted by the inhalation route in rats and mice. In a 2-year carcinogenicity study in Sprague-Dawley rats, mometasone furoate demonstrated no statistically significant increase of tumors at inhalation doses up to 67 mcg/kg (approximately 0.04 times the estimated maximum clinical topical dose from ELOCON Cream on a mcg/m2 basis). In a 19-month carcinogenicity study in Swiss CD-1 mice, mometasone furoate demonstrated no statistically significant increase in the incidence of tumors at inhalation doses up to 160 mcg/kg (approximately 0.05 times the estimated maximum clinical topical dose from ELOCON Cream on a mcg/m2 basis).¡± À¨ºÅÀïÃæµÄÓ¦¸ÃÔõô·ÒëÄØ£¿¾ßÌ庬ÒåÊÇʲô£¿ |
» ²ÂÄãϲ»¶
307ÖÐÒ½¿¼Ñе÷¼Á
ÒѾÓÐ4È˻ظ´
ͨÐŹ¤³ÌÇóµ÷¼Á£¡£¡£¡
ÒѾÓÐ5È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
ҩѧÇóµ÷¼Á
ÒѾÓÐ13È˻ظ´
Ò»Ö¾Ô¸»ªÖÐũҵ071010£¬320Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
290µ÷¼ÁÉúÎï0860
ÒѾÓÐ43È˻ظ´
Ò»Ö¾Ô¸»¦9£¬ÉúÎïѧ326Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
296Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
ÉúÎïѧµ÷¼Á
ÒѾÓÐ9È˻ظ´
0854Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
Ingenol Mebutate 2012Äê1ÔÂFDAÅú×¼µÄÖÎÁÆÆ¤·ô²¡µÄÒ©Îï
ÒѾÓÐ15È˻ظ´
·ÒëFDA×¢²áÍâÎÄÊ飬ÎÒÃÇÒ»ÆðŬÁ¦°É£¡
ÒѾÓÐ11È˻ظ´

Rio2016
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 28 (СѧÉú)
- ¹ó±ö: 0.013
- ½ð±Ò: 3301.7
- É¢½ð: 25
- ºì»¨: 6
- Ìû×Ó: 300
- ÔÚÏß: 243.3Сʱ
- ³æºÅ: 1910117
- ×¢²á: 2012-07-25
- רҵ: ¿¹Ö×ÁöÒ©ÎïÒ©Àí
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
zhtear99: ½ð±Ò+3, ¸ÐлÈÈÐÄÓ¦Öú£¬½âÊ͵ĺÜÏêϸ¡£BB½±ÀøÏ£¬»¶Ó³£À´¹þ~~ 2013-04-16 11:51:22
taizicun: ½ð±Ò+15, ¡ï¡ï¡ïºÜÓаïÖú, лл~½ð±ÒÈ«¸øÄãÁË£¡ 2013-04-16 13:18:12
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
zhtear99: ½ð±Ò+3, ¸ÐлÈÈÐÄÓ¦Öú£¬½âÊ͵ĺÜÏêϸ¡£BB½±ÀøÏ£¬»¶Ó³£À´¹þ~~ 2013-04-16 11:51:22
taizicun: ½ð±Ò+15, ¡ï¡ï¡ïºÜÓаïÖú, лл~½ð±ÒÈ«¸øÄãÁË£¡ 2013-04-16 13:18:12
|
In a 19-month carcinogenicity study in Swiss CD-1 mice, mometasone furoate demonstrated no statistically significant increase in the incidence of tumors at inhalation doses up to 160 mcg/kg (approximately 0.05 times the estimated maximum clinical topical dose from ELOCON Cream on a mcg/m2 basis). ÔÚÒ»¸ö19¸öÔµÄСÊóÖ°©Ñо¿ÖУ¬¿·ËáĪÃ×ËɵÄÎüÈë¼ÁÁ¿´ïµ½160 ΢¿Ë/¹«½ïʱÔÚÖ×Áö·¢ÉúÂÊÉÏûÓÐͳ¼ÆµÄÏÔÖøÐÔÔö¼Ó£¨´óԼΪ ĪÃ×Ëɸà¼Á Ô¤¼Æ×î´óÁÙ´²¾Ö²¿¼ÁÁ¿£¨°´Î¢¿Ë/ƽ·½Ã׸øÒ©£©µÄ0.05±¶£©¡£ ÍâÓÃÒ©£º°´Î¢¿Ë/ƽ·½Ã׸øÒ©£¬ÏÖÔÚ¶¯ÎïʵÑéÒ²ÓÐºÜ¶à°´Ãæ»ý¸øÒ©µÄ¡£ ËùνµÄ°´ÌåÖØ¸øÒ©£¬¶¼ÊÇÓÃÏàӦϵÊý»»Ëã¹ýÈ¥µÄ¡£ |

2Â¥2013-04-16 11:20:49













»Ø¸´´ËÂ¥